The plight of descriptive dermatology and clinical investigation in an “evidence-based” world - 01/09/11
Doi : 10.1067/mjd.2002.119653
Ronni Wolf, MDa, Binnur Tüzün, MDb, Yalcin Tüzün, MDc
Tel-Aviv, Israel, and Edirne and Istanbul, Turkey
From the Department of Dermatology, Tel-Aviv Sourasky Medical Center, and the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviva; the Department of Dermatology, Trakya University, Medical Faculty, Edirneb; and the Department of Dermatology, Istanbul University, Cerrahpasa Medical Faculty.c
Abstract |
J Am Acad Dermatol 2002;46:637-8.
Le texte complet de cet article est disponible en PDF. | The opinions expressed herein are solely those of the writers and do not necessarily reflect the opinions of the institutions with which the writers are associated. |
| Reprint requests: Ronni Wolf, MD, Department of Dermatology, Tel-Aviv Sourasky Medical Center, 6 Weizman St, Tel-Aviv, 64239 Israel. E-mail: wolf_r@netvision.net.il. |
© 2002
American Academy of Dermatology, Inc. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 46 - N° 4
P. 637-638 - avril 2002 Retour au numéro
Article précédent
- Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis siné myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness?
- Richard D. Sontheimer
- What to do with basal cell carcinoma leftovers
- Leonard M. Dzubow
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?